Revised forecast
Fiscal year ending September 2026 · Full yearPrevious forecast published Released 13 November 2025The bar length represents the relative magnitude of change, based on the item that changed the most in this document. The percentage change shown by the dotted line is calculated from the two reported figures because the company did not provide the rate.
Lower selling and purchase prices accompanying the decline in trading card prices; sluggish advertising demand; increasing difficulty in continuing the operations of アクセルメディカ株式会社; the impact of inventory valuation; non-operating expenses; extraordinary losses including provisions for doubtful accounts, impairment losses, losses on redemption of convertible bonds and inventory valuation losses; and recognition of adjustments to corporate income taxes due to the reversal of deferred tax assets.
Provision for doubtful accounts: ¥97 million; impairment losses of ¥46 million on goodwill relating to 株式会社crafty and the store equipment of the cardéria Ikebukuro Store; loss on redemption of convertible bonds: ¥36 million; inventory valuation losses: ¥12 million; and other extraordinary losses, totaling ¥202 million. Separately, ¥11 million in adjustments to corporate income taxes was recorded.
| Item | Details |
|---|---|
| Net Sales | ¥1,308 million → ¥1,264 million（-3.4%） |
| Operating profit | ¥-486 million → ¥-497 million |
| Ordinary income | ¥-501 million → ¥-555 million |
| Profit attributable to owners of the parent | ¥-502 million → ¥-762 million |
| Net income per share | Not disclosed → -24.36 Yen/sen |
| Fiscal Period Covered | Fiscal year ending September 2026 |
| Period Covered | Full year |
| Publication date of previous forecast | Released 13 November 2025 |
| Previous-period results | Net sales: ¥973 million; operating income: ¥520 million loss; ordinary income: ¥672 million loss; net income attributable to owners of the parent: ¥763 million loss; net income per share: ¥49.58 loss (fiscal year ended September 2025) |
| Reason for the revision | Lower selling and purchase prices accompanying the decline in trading card prices; sluggish advertising demand; increasing difficulty in continuing the operations of アクセルメディカ株式会社; the impact of inventory valuation; non-operating expenses; extraordinary losses including provisions for doubtful accounts, impairment losses, losses on redemption of convertible bonds and inventory valuation losses; and recognition of adjustments to corporate income taxes due to the reversal of deferred tax assets. |
| Details and amount of extraordinary loss | Provision for doubtful accounts: ¥97 million; impairment losses of ¥46 million on goodwill relating to 株式会社crafty and the store equipment of the cardéria Ikebukuro Store; loss on redemption of convertible bonds: ¥36 million; inventory valuation losses: ¥12 million; and other extraordinary losses, totaling ¥202 million. Separately, ¥11 million in adjustments to corporate income taxes was recorded. |
| Consolidated / non-consolidated | Consolidated |
Items this document does not state (1)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Lower selling and purchase prices due to the unexpected decline in trading card prices; sluggish advertising demand; increasing difficulty in continuing the operations of アクセルメディカ株式会社; the impact of inventory valuation; non-operating expenses associated with the third-party allotment and other transactions; extraordinary losses including provisions for doubtful accounts, impairment losses, losses on redemption of convertible bonds and inventory valuation losses; and recognition of adjustments to corporate income taxes due to the reversal of deferred tax assets.